These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26795965)

  • 1. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model.
    He Q; Li X; Liu C; Su L; Xia Z; Li X; Li Y; Li L; Yan T; Feng Q; Xiao L
    Appl Microbiol Biotechnol; 2016 May; 100(10):4485-94. PubMed ID: 26795965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota.
    Yang F; Ni B; Liu Q; He F; Li L; Zhong X; Zheng X; Lu J; Chen X; Lin H; Xu R; He Y; Zhang Q; Zou X; Chen W
    Stem Cell Res Ther; 2022 Sep; 13(1):475. PubMed ID: 36104756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis.
    Kozik AJ; Nakatsu CH; Chun H; Jones-Hall YL
    PLoS One; 2019; 14(11):e0225079. PubMed ID: 31703107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.
    Li Y; Sun R; Lai C; Liu K; Yang H; Peng Z; Xu D; Huang F; Tang K; Peng Y; Liu X
    J Transl Med; 2024 May; 22(1):518. PubMed ID: 38816750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats.
    Li M; Li Z; Wen S; Liu Y; Wang Y; Tang L
    Future Microbiol; 2016 Jul; 11():887-902. PubMed ID: 27415182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.
    Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.
    Kao D; Hotte N; Gillevet P; Madsen K
    J Clin Gastroenterol; 2014 Aug; 48(7):625-8. PubMed ID: 24667590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights.
    Foligné B; Plé C; Titécat M; Dendooven A; Pagny A; Daniel C; Singer E; Pottier M; Bertin B; Neut C; Deplanque D; Dubuquoy L; Desreumaux P; Capron M; Standaert A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31212833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Lipocalin-2 as a Sensitive and Noninvasive Biomarker in the TNBS Crohn's Inflammatory Bowel Disease Model.
    Hsieh H; Morin J; Filliettaz C; Varada R; LaBarre S; Radi Z
    Toxicol Pathol; 2016 Dec; 44(8):1084-1094. PubMed ID: 27585983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.
    Kang S; Denman SE; Morrison M; Yu Z; Dore J; Leclerc M; McSweeney CS
    Inflamm Bowel Dis; 2010 Dec; 16(12):2034-42. PubMed ID: 20848492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
    Eun CS; Kwak MJ; Han DS; Lee AR; Park DI; Yang SK; Kim YS; Kim JF
    BMC Gastroenterol; 2016 Feb; 16():28. PubMed ID: 26922889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.
    Rajca S; Grondin V; Louis E; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Paintaud G; Piver E; Allez M; Mary JY; Sokol H; Colombel JF; Seksik P
    Inflamm Bowel Dis; 2014 Jun; 20(6):978-86. PubMed ID: 24788220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive Enteral Nutrition Beneficially Modulates Gut Microbiome in a Preclinical Model of Crohn's-like Colitis.
    Geesala R; Recharla N; Zhang K; Johnson JC; Golovko G; Khanipov K; Brining DL; Shi XZ
    Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease.
    Vaughn BP; Vatanen T; Allegretti JR; Bai A; Xavier RJ; Korzenik J; Gevers D; Ting A; Robson SC; Moss AC
    Inflamm Bowel Dis; 2016 Sep; 22(9):2182-90. PubMed ID: 27542133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook.
    Shen Z; Zhu C; Quan Y; Yuan W; Wu S; Yang Z; Luo W; Tan B; Wang X
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1804-1812. PubMed ID: 28677158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.